Literature DB >> 14633256

Prenatal genotyping of RHD and SRY using maternal blood.

I Randen1, R Hauge, J Kjeldsen-Kragh, M K Fagerhol.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of the study was to perform fetal RHD genotyping in maternal plasma using a fluorescent polymerase chain reaction (PCR) technique. Duplex PCR, amplifying RHD and SRY in the same tube, was undertaken. The effect of varying storage temperatures on the concentration of fetal DNA was investigated in a separate study involving 10 RhD-negative pregnant women.
MATERIALS AND METHODS: Primers and probes for the RHD gene's exon 7 and the sex-determining region, Y, were designed, and monoplex and duplex PCR were performed. Blood samples from 10 RhD-negative women were split into four and treated in four different ways before measuring the concentration of fetal DNA by quantitative PCR.
RESULTS: DNA extracted from the plasma of 114 RhD-negative pregnant women was tested for the presence of fetal RHD. The discrepancy between genotyping and serological RhD typing of the babies postpartum was 8% when counting one positive replicate as a positive result. Duplex PCR, amplifying RHD and SRY in the same tube, showed a reduced sensitivity for amplification of the SRY gene segment. There was a statistically significant reduction of fetal DNA in blood samples stored at room temperature for 48 h compared with the same sample stored at a temperature of <10 degrees C for the same length of time.
CONCLUSIONS: This method is not suitable for routine analysis because of the lack of a positive control for RHD-negative female fetuses and a decrease in PCR sensitivity when performing duplex PCR. Fetal DNA in maternal plasma is better preserved when the blood sample is kept cool.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633256     DOI: 10.1111/j.0042-9007.2003.00371.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  The Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies.

Authors:  Thomasz Adamczyk; Andrea Doescher; Paul V Haydock; Russ Aldrich; Eduard K Petershofen; Thomas H Müller
Journal:  Transfus Med Hemother       Date:  2015-10-26       Impact factor: 3.747

2.  Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran.

Authors:  Mohammad Hossein Ahmadi; Sedigheh Hantuoshzadeh; Mohammad Ali Okhovat; Nahid Nasiri; Azita Azarkeivan; Naser Amirizadeh
Journal:  Indian J Hematol Blood Transfus       Date:  2015-11-06       Impact factor: 0.900

3.  Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.

Authors:  Christelle Rouillac-Le Sciellour; Philippe Puillandre; Rolande Gillot; Céline Baulard; Sylvain Métral; Caroline Le Van Kim; Jean-Pierre Cartron; Yves Colin; Yves Brossard
Journal:  Mol Diagn       Date:  2004

Review 4.  Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis.

Authors:  Caroline F Wright; Yinghui Wei; Julian P T Higgins; Gurdeep S Sagoo
Journal:  BMC Res Notes       Date:  2012-09-01

5.  Pre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHD.

Authors:  Frederik Banch Clausen; Tanja Roien Jakobsen; Klaus Rieneck; Grethe Risum Krog; Leif Kofoed Nielsen; Ann Tabor; Morten Hanefeld Dziegiel
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.